sirolimus

Generic: sirolimus

Labeler: dr. reddy's laboratories limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name sirolimus
Generic Name sirolimus
Labeler dr. reddy's laboratories limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

sirolimus 2 mg/1

Manufacturer
Dr. Reddy's Laboratories Limited

Identifiers & Regulatory

Product NDC 55111-654
Product ID 55111-654_f9a9d4b5-1c61-a2e6-5511-84b3f4f9b24b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA201578
Listing Expiration 2026-12-31
Marketing Start 2014-10-27

Pharmacologic Class

Established (EPC)
mtor inhibitor immunosuppressant [epc] kinase inhibitor [epc]
Mechanism of Action
mtor inhibitors [moa] protein kinase inhibitors [moa]
Physiologic Effect
decreased immunologic activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55111654
Hyphenated Format 55111-654

Supplemental Identifiers

RxCUI
349208 360110
UPC
0355111654018
UNII
W36ZG6FT64
NUI
N0000175550 N0000175625 N0000175624 N0000175605 N0000175076

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name sirolimus (source: ndc)
Generic Name sirolimus (source: ndc)
Application Number ANDA201578 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (55111-654-01)
  • 30 TABLET in 1 BOTTLE (55111-654-30)
source: ndc

Packages (2)

Ingredients (1)

sirolimus (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f9a9d4b5-1c61-a2e6-5511-84b3f4f9b24b", "openfda": {"nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "upc": ["0355111654018"], "unii": ["W36ZG6FT64"], "rxcui": ["349208", "360110"], "spl_set_id": ["2e6130e5-fa94-dcf8-605c-817bf396e93d"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (55111-654-01)", "package_ndc": "55111-654-01", "marketing_start_date": "20141027"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (55111-654-30)", "package_ndc": "55111-654-30", "marketing_start_date": "20141027"}], "brand_name": "Sirolimus", "product_id": "55111-654_f9a9d4b5-1c61-a2e6-5511-84b3f4f9b24b", "dosage_form": "TABLET", "pharm_class": ["Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "55111-654", "generic_name": "Sirolimus", "labeler_name": "Dr. Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sirolimus", "active_ingredients": [{"name": "SIROLIMUS", "strength": "2 mg/1"}], "application_number": "ANDA201578", "marketing_category": "ANDA", "marketing_start_date": "20141027", "listing_expiration_date": "20261231"}